| Description |
| Product Type |
Product Size |
| Injection
|
6'S |
| Product Company |
| Chiesi Pharmaceuticals |
Meglumine indomethicinate 77.2+50mg
|
| Product Type |
Product Size |
| Tablet |
30'S |
| Product Company |
| Sami Pharmaceutical |
Nimesulide 100mg |
| Product Type |
Product Size |
| Capsules |
20'S |
| Product Company |
| Brookes Pharmaceutical |
Diclofenac sodium 100mg |
| Product Type |
Product Size |
| Tablet |
30'S |
| Product Company |
| Sami Pharmaceutical |
Diclofenac Sodium 100mg |
| Product Type |
Product Size |
| Injection |
1'S |
| Product Company |
| Asian Continental |
Diclofenac Sodium 75mg |
| Product Type |
Product Size |
Product Company |
| Injection |
1'S |
Aqvida |
|
| Content | Indomethacin is an anti-inflammatory agent, used to combat pain and inflammation in various conditions
| Nimesulide is a non-selective non-steroidal anti-inflammatory drug (NSAID). It is used to treat: acute (short-term) pain, painful osteoarthritis (swelling in the joints) , primary dysmenorrhoea (period pains). | The Sustain Release tablet form of diclofenac is used to reduce pain, swelling (inflammation), and joint stiffness from arthritis. | This medicine is used in the management of muscular and skeletal disorder pain, rheumatoid arthritis, osteoarthrosis, ankylosing spondylitis (arthritis affecting joints of spine), acute gout (complex form of arthritis with extreme pain and swelling of joints) and chronic juvenile arthritis (arthritis in children). | Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).Label NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. | Oxaliplatin is a platinum-based chemotherapy drug in the same family as cisplatin and carboplatin. It is typically administered in combination with fluorouracil and leucovorin in a combination known as Folfox for the treatment of colorectal cancer. Compared to cisplatin the two amine groups are replaced by cyclohexyldiamine for improved antitumour activity. The chlorine ligands are replaced by the oxalato bidentate derived from oxalic acid in order to improve water solubility. |
Reviews
There are no reviews yet.